Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 35.20

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (102)	2/27/2003 5:52:03 PM
From: keokalani'nui	Read Replies (1) of 566

Anyone know how to save the slides to disk, and what program to use to successfully read them? --Will unblind the allergy trail May '03. Hadn't known it before, but even though n=20, it is blinded, plo controlled, cross-over, challenge trial. Nasal spray 10 min. prior to challenge. Using tiny sponges to measure all the effects, from baseline. --HCV IND hoped for 3Q03, and mnfg and formulation for the prerequisite chronic tox study nearly complete. --Interesting that RA candidate will be #3 IND 1Q04, same/similar kinase target--SyK--as is the x112 target in Mast Cell; apparently becuase IgGFc receptor signaling activates macrophages, B-cells and mast cells through the same Syk common pathway. Or something like that. --Acknowledges they need to raise equity this year and need another partner. Really, this company has not had a fair shake. With a needed financing so obvious, don't hope for any help from the shorts.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next